Table 2.
Number of Subjects per Immunocompromising Condition
| Bacterial, n | Viral, n | NI, n | Total, n (%) | |
|---|---|---|---|---|
| Immunomodulatory agent | 21 | 16 | 22 | 59 (44.0) |
| Solid-organ transplant | 25 | 5 | 8 | 38 (28.4) |
| Chemotherapy | 14 | 5 | 9 | 28 (20.9) |
| HIV/AIDS | 4 | 2 | 3 | 9 (6.7) |
| Total | 64 | 28 | 42 | 134 |
| Proportion, % | 47.8 | 20.8 | 31.3 | … |
All patients with HIV/AIDS had a CD4 count <200 cells/mm3. Immunomodulatory agents included disease modifying antirheumatic drugs, chronic steroids (>10 mg of prednisone equivalent daily for >30 days), and acute high-dose steroids (60 mg prednisone equivalent for ≥3 days).
Abbreviations: HIV, human immunodeficiency virus; NI, noninfectious illness.